News

Mon, 03/06/2019
Publication: Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.
Muenster. For the first time scientists from the University of Münster could show that multiple sclerosis (MS) alters the energy metabolism of T cells during acute phases of disease exacerbation. Therapeutic interventions targeting the metabolism of activated T cells display new potential avenues for treatment of patients with MS affecting around 250,000 people in Germany. The […]...more
Mon, 29/04/2019
Publication: Calcium influx through plasma-membrane nanoruptures drives axon degeneration in a model of multiple sclerosis.
Munich.  Here SFB researchers from Munich use in vivo calcium imaging in a multiple sclerosis model to show that cytoplasmic calcium levels determine the choice between axon loss and survival. Calcium can enter the axon through nanoscale ruptures of the axonal plasma membrane that are induced in inflammatory lesions. Neuron doi: 10.1016/ j.neuron.2018.12.023...more
Tue, 04/12/2018
SFB 128 International Symposium
SFB 128. We are happy to announce the international Symposium of the Collaborative Research Centre 128 “Multiple Sclerosis” taking place from Sunday, September 15th, till Tuesday, September 17th, 2019 in the Rhine Main region. Full details of the event will follow....more


Fri, 05/12/2014 | International Neuroimmunology Conference in Mainz

From 9-13 November 2014, over 1000 neuroimmunologists from all over the world met at the 12th International Congress for Neuroimmunology in Mainz. With 70 invited speakers and 40 chairs representing experts in the field, as well as 50 early career researchers selected to present their research and hundreds of others presenting posters, the scientific program was varied and stimulating, showcasing the newest and most exciting developments in the field of neuroimmunology.

The success of the conference was thanks to the local organizing committee consisting of prominent neuroimmunologists from Germany, Austria and Switzerland. Among them were most of the members of the CRC-TR-128 Steering Board, and in particular Frauke Zipp and Ari Waisman were the conference chairs.

The 12th ISNI Congress was a particularly important event for the CRC-TR-128, as multiple sclerosis was a central theme of the conference. Many of our principal investigators were invited speakers and chairs, and 70 additional members attended. The CRC-TR-128 also sponsored a symposium for early career researchers to present their work in the area of neuroinflammation.

You can also see Frauke Zipp talking about MS at the conference in an interview with the SWR Landesschau Aktuell (in German).

CRC member Erik Ellwardt speaking in the CRC sponsored session

CRC member Erik Ellwardt speaking in the CRC sponsored session

 

Plenary Lecture at the 12th International Congress for Neuroimmunology

Plenary Lecture at the 12th International Congress for Neuroimmunology

 

Conference Chairs and CRC Steering Board Members, Frauke Zipp and Ari Waisman

Conference Chairs and CRC Steering Board Members, Frauke Zipp and Ari Waisman